Copyright Reports & Markets. All rights reserved.

USA Interventional Cardiovascular Device Market Report 2018

Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Interventional Cardiovascular Device Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Imaging System Market Performance (Volume)
      • 2.1.2 Catheter Market Performance (Volume)
      • 2.1.3 PTCA Balloon Market Performance (Volume)
      • 2.1.4 Stent Market Performance (Volume)
      • 2.1.5 PTCA Guidewire Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Imaging System Market Performance (Value)
      • 2.1.2 Catheter Market Performance (Value)
      • 2.1.3 PTCA Balloon Market Performance (Value)
      • 2.1.4 Stent Market Performance (Value)
      • 2.1.5 PTCA Guidewire Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospital Market Performance (Volume)
      • 3.1.2 Clinic Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 GE Healthcare
      • 4.1.1 GE Healthcare Profiles
      • 4.1.2 GE Healthcare Product Information
      • 4.1.3 GE Healthcare Interventional Cardiovascular Device Business Performance
      • 4.1.4 GE Healthcare Interventional Cardiovascular Device Business Development and Market Status
    • 4.2 Boston Scientific
      • 4.2.1 Boston Scientific Profiles
      • 4.2.2 Boston Scientific Product Information
      • 4.2.3 Boston Scientific Interventional Cardiovascular Device Business Performance
      • 4.2.4 Boston Scientific Interventional Cardiovascular Device Business Development and Market Status
    • 4.3 Philips
      • 4.3.1 Philips Profiles
      • 4.3.2 Philips Product Information
      • 4.3.3 Philips Interventional Cardiovascular Device Business Performance
      • 4.3.4 Philips Interventional Cardiovascular Device Business Development and Market Status
    • 4.4 Volcano Therapeutics
      • 4.4.1 Volcano Therapeutics Profiles
      • 4.4.2 Volcano Therapeutics Product Information
      • 4.4.3 Volcano Therapeutics Interventional Cardiovascular Device Business Performance
      • 4.4.4 Volcano Therapeutics Interventional Cardiovascular Device Business Development and Market Status
    • 4.5 Argon Medical
      • 4.5.1 Argon Medical Profiles
      • 4.5.2 Argon Medical Product Information
      • 4.5.3 Argon Medical Interventional Cardiovascular Device Business Performance
      • 4.5.4 Argon Medical Interventional Cardiovascular Device Business Development and Market Status
    • 4.6 Spectranetics
      • 4.6.1 Spectranetics Profiles
      • 4.6.2 Spectranetics Product Information
      • 4.6.3 Spectranetics Interventional Cardiovascular Device Business Performance
      • 4.6.4 Spectranetics Interventional Cardiovascular Device Business Development and Market Status
    • 4.7 Angio Dynamics
      • 4.7.1 Angio Dynamics Profiles
      • 4.7.2 Angio Dynamics Product Information
      • 4.7.3 Angio Dynamics Interventional Cardiovascular Device Business Performance
      • 4.7.4 Angio Dynamics Interventional Cardiovascular Device Business Development and Market Status
    • 4.8 AccessClosure
      • 4.8.1 AccessClosure Profiles
      • 4.8.2 AccessClosure Product Information
      • 4.8.3 AccessClosure Interventional Cardiovascular Device Business Performance
      • 4.8.4 AccessClosure Interventional Cardiovascular Device Business Development and Market Status
    • 4.9 Merit Medical Systems
      • 4.9.1 Merit Medical Systems Profiles
      • 4.9.2 Merit Medical Systems Product Information
      • 4.9.3 Merit Medical Systems Interventional Cardiovascular Device Business Performance
      • 4.9.4 Merit Medical Systems Interventional Cardiovascular Device Business Development and Market Status
    • 4.10 B. Braun
      • 4.10.1 B. Braun Profiles
      • 4.10.2 B. Braun Product Information
      • 4.10.3 B. Braun Interventional Cardiovascular Device Business Performance
      • 4.10.4 B. Braun Interventional Cardiovascular Device Business Development and Market Status
    • 4.11 C. R. Bard
    • 4.12 Marine Polymer Technologies
    • 4.13 Philips

    5 Market Performance for Manufacturers

    • 5.1 USA Interventional Cardiovascular Device Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Interventional Cardiovascular Device Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Interventional Cardiovascular Device Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Interventional Cardiovascular Device Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Interventional Cardiovascular Device Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Interventional Cardiovascular Device Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Interventional Cardiovascular Device Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Interventional Cardiovascular Device Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Interventional Cardiovascular Device Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Interventional Cardiovascular Device Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Interventional Cardiovascular Device Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Interventional Cardiovascular Device Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Interventional Cardiovascular Device Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Interventional Cardiovascular Device Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Interventional Cardiovascular Device Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Interventional Cardiovascular Device Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Interventional Cardiovascular Device Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Interventional Cardiovascular Device Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Interventional Cardiovascular Device Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Interventional Cardiovascular Device Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Interventional Cardiovascular Device Market Performance (Sales Point)

    • 7.1 USA Interventional Cardiovascular Device Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Interventional Cardiovascular Device Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Interventional Cardiovascular Device Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Interventional Cardiovascular Device Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Interventional Cardiovascular Device Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Interventional Cardiovascular Device Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Interventional Cardiovascular Device Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Interventional Cardiovascular Device Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Interventional Cardiovascular Device Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospital Industry
    • 11.2 Clinic Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Interventional Cardiovascular Device Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Interventional Cardiovascular Device Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Imaging System Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Catheter Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 PTCA Balloon Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Stent Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Hospital Sales and and Growth Rate 2019-2024
      • 12.4.3 Clinic Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Interventional Cardiovascular Device Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Interventional Cardiovascular Device Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Interventional Cardiovascular Device for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Interventional Cardiovascular Device market competition by top manufacturers/players, with Interventional Cardiovascular Device sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GE Healthcare
    Boston Scientific
    Philips
    Volcano Therapeutics
    Argon Medical
    Spectranetics
    Angio Dynamics
    AccessClosure
    Merit Medical Systems
    B. Braun
    C. R. Bard
    Marine Polymer Technologies
    Cordis

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Imaging System
    Catheter
    PTCA Balloon
    Stent
    PTCA Guidewire
    Other

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Interventional Cardiovascular Device for each application, including
    Hospital
    Clinic

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now